company background image
EVH logo

Evolent Health NYSE:EVH Stock Report

Last Price

US$32.79

Market Cap

US$3.7b

7D

0.6%

1Y

2.5%

Updated

28 Mar, 2024

Data

Company Financials +

EVH Stock Overview

Evolent Health, Inc., through its subsidiary, Evolent Health LLC, offers specialty care management services in oncology, cardiology, and musculoskeletal markets in the United States.

EVH fundamental analysis
Snowflake Score
Valuation3/6
Future Growth4/6
Past Performance0/6
Financial Health2/6
Dividends0/6

Evolent Health, Inc. Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Evolent Health
Historical stock prices
Current Share PriceUS$32.79
52 Week HighUS$36.70
52 Week LowUS$23.33
Beta1.54
1 Month Change-4.01%
3 Month Change-0.73%
1 Year Change2.50%
3 Year Change58.64%
5 Year Change167.02%
Change since IPO73.86%

Recent News & Updates

Evolent Health (NYSE:EVH) Is Experiencing Growth In Returns On Capital

Mar 12
Evolent Health (NYSE:EVH) Is Experiencing Growth In Returns On Capital

Evolent Health (NYSE:EVH) Takes On Some Risk With Its Use Of Debt

Jan 17
Evolent Health (NYSE:EVH) Takes On Some Risk With Its Use Of Debt

Recent updates

Evolent Health (NYSE:EVH) Is Experiencing Growth In Returns On Capital

Mar 12
Evolent Health (NYSE:EVH) Is Experiencing Growth In Returns On Capital

Evolent Health (NYSE:EVH) Takes On Some Risk With Its Use Of Debt

Jan 17
Evolent Health (NYSE:EVH) Takes On Some Risk With Its Use Of Debt

Many Still Looking Away From Evolent Health, Inc. (NYSE:EVH)

Dec 21
Many Still Looking Away From Evolent Health, Inc. (NYSE:EVH)

Evolent Health (NYSE:EVH) Is Looking To Continue Growing Its Returns On Capital

Nov 30
Evolent Health (NYSE:EVH) Is Looking To Continue Growing Its Returns On Capital

A First Evaluation On Evolent Health

Oct 04

Does Evolent Health (NYSE:EVH) Have A Healthy Balance Sheet?

Sep 29
Does Evolent Health (NYSE:EVH) Have A Healthy Balance Sheet?

There's Been No Shortage Of Growth Recently For Evolent Health's (NYSE:EVH) Returns On Capital

Sep 01
There's Been No Shortage Of Growth Recently For Evolent Health's (NYSE:EVH) Returns On Capital

An Intrinsic Calculation For Evolent Health, Inc. (NYSE:EVH) Suggests It's 47% Undervalued

Aug 04
An Intrinsic Calculation For Evolent Health, Inc. (NYSE:EVH) Suggests It's 47% Undervalued

Evolent Health: Business Economics Still Appealing, Reiterate Buy

Jul 19

Cautious Investors Not Rewarding Evolent Health, Inc.'s (NYSE:EVH) Performance Completely

Jun 14
Cautious Investors Not Rewarding Evolent Health, Inc.'s (NYSE:EVH) Performance Completely

Evolent Health (NYSE:EVH) Takes On Some Risk With Its Use Of Debt

May 30
Evolent Health (NYSE:EVH) Takes On Some Risk With Its Use Of Debt

An Intrinsic Calculation For Evolent Health, Inc. (NYSE:EVH) Suggests It's 34% Undervalued

May 02
An Intrinsic Calculation For Evolent Health, Inc. (NYSE:EVH) Suggests It's 34% Undervalued

Evolent Health (NYSE:EVH) Shareholders Will Want The ROCE Trajectory To Continue

Apr 17
Evolent Health (NYSE:EVH) Shareholders Will Want The ROCE Trajectory To Continue

Evolent Health GAAP EPS of $0.11 beats by $0.13, revenue of $382.4M beats by $9.47M

Feb 22

Is Evolent Health (NYSE:EVH) A Risky Investment?

Feb 19
Is Evolent Health (NYSE:EVH) A Risky Investment?

Evolent Health: Strengthening Fundamentals, Investing At High Rates Of Return

Feb 15

Is Evolent Health, Inc. (NYSE:EVH) Potentially Undervalued?

Feb 01
Is Evolent Health, Inc. (NYSE:EVH) Potentially Undervalued?

Evolent Health (NYSE:EVH) Might Have The Makings Of A Multi-Bagger

Jan 14
Evolent Health (NYSE:EVH) Might Have The Makings Of A Multi-Bagger

Evolent spikes as Humana partnership expands

Jan 12

Is Evolent Health, Inc. (NYSE:EVH) Trading At A 49% Discount?

Dec 27
Is Evolent Health, Inc. (NYSE:EVH) Trading At A 49% Discount?

Evolent Health offered $23.5M class action securities settlement

Sep 19

Evolent Health's (NYSE:EVH) Returns On Capital Are Heading Higher

Sep 18
Evolent Health's (NYSE:EVH) Returns On Capital Are Heading Higher

Evolent Health: Improving Financials, But There's More

Aug 31

Is Evolent Health (NYSE:EVH) A Risky Investment?

Aug 05
Is Evolent Health (NYSE:EVH) A Risky Investment?

Evolent Health initiated at outperform at RBC on organic revenue growth opportunity

Jul 29

Evolent Health: Strong Growth, Priced At 2x Sales, What To Know

Jul 11

Evolent Health: Healthy Growth, But That Is About It

Jun 30

Shareholder Returns

EVHUS Healthcare ServicesUS Market
7D0.6%-0.5%0.2%
1Y2.5%5.3%28.1%

Return vs Industry: EVH underperformed the US Healthcare Services industry which returned 5.7% over the past year.

Return vs Market: EVH underperformed the US Market which returned 28.8% over the past year.

Price Volatility

Is EVH's price volatile compared to industry and market?
EVH volatility
EVH Average Weekly Movement5.6%
Healthcare Services Industry Average Movement11.0%
Market Average Movement6.1%
10% most volatile stocks in US Market16.8%
10% least volatile stocks in US Market3.0%

Stable Share Price: EVH has not had significant price volatility in the past 3 months.

Volatility Over Time: EVH's weekly volatility (6%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
20114,700Seth Blackleyhttps://www.evolent.com

Evolent Health, Inc., through its subsidiary, Evolent Health LLC, offers specialty care management services in oncology, cardiology, and musculoskeletal markets in the United States. The company provides platform for health plan administration and value-based business infrastructure. It offers administrative services, such as health plan services, pharmacy benefits management, risk management, analytics and reporting, and leadership and management; and Identifi, a proprietary technology system that aggregates and analyzes data, manages care workflows, and engages patients.

Evolent Health, Inc. Fundamentals Summary

How do Evolent Health's earnings and revenue compare to its market cap?
EVH fundamental statistics
Market capUS$3.73b
Earnings (TTM)-US$142.26m
Revenue (TTM)US$1.96b

1.9x

P/S Ratio

-26.3x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
EVH income statement (TTM)
RevenueUS$1.96b
Cost of RevenueUS$1.50b
Gross ProfitUS$460.47m
Other ExpensesUS$602.73m
Earnings-US$142.26m

Last Reported Earnings

Dec 31, 2023

Next Earnings Date

n/a

Earnings per share (EPS)-1.25
Gross Margin23.45%
Net Profit Margin-7.24%
Debt/Equity Ratio47.9%

How did EVH perform over the long term?

See historical performance and comparison
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.